R

Revolution Medicines

Clinical-stage oncology company developing RAS inhibitors

Associate Director - Healthcare Law

Legal Counsel & Legal SupportPosted on Nov 9
Full-timeRemote in USA

About the Job

Requirements

  • A Juris Doctor (JD) degree from an accredited law school is required.
  • Active bar membership in good standing in at least one U.S. jurisdiction is required; candidates based in California must have California bar membership or be eligible to register as Registered In-House Counsel.
  • At least 8 years of relevant legal experience, including meaningful FDA advertising and promotion and healthcare compliance experience gained in-house at a pharmaceutical or biotechnology company and/or in a life sciences regulatory practice, is required.
  • Direct experience serving as legal reviewer on promotional review committees (PRC/MRC or MLR) is required.
  • Strong working knowledge of the FDA regulatory framework, the Federal Food, Drug, and Cosmetic Act (FDCA), Anti-Kickback Statute (AKS), False Claims Act (FCA), Sunshine Act/Open Payments, and Health Insurance Portability and Accountability Act (HIPAA) is required.
  • Ability to advise cross-functional clinical, medical, and commercial teams strategically is required.
  • Ability to communicate complex legal risks in clear, business-centric terms; manage stakeholders and negotiate; manage high volume and competing priorities; maintain confidentiality and high ethical standards; and work collaboratively, flexibly, and pragmatically is required.

Responsibilities

  • Serve as lead brand counsel and key legal business partner for an assigned daraxonrasib indication, partnering with Commercial, Medical Affairs, Regulatory, Compliance, and other functions to provide practical, risk-calibrated advice on commercialization matters.
  • Lead legal launch readiness for the assigned indication, including pre-approval communications, development of core claims and launch materials, review of launch campaigns, and coordination with Regulatory on labeling and approval timelines.
  • Serve as legal reviewer on the Promotional Review Committee (PRC) and Medical Review Committee (MRC), reviewing promotional materials—including healthcare professional and consumer/direct-to-consumer, digital, social media, sales training, speaker program, and congress/exhibit materials—and non-promotional/medical scientific exchange materials for compliance with the FDCA, FDA regulations and guidance, and company policy.
  • Advise on the line between promotion and scientific exchange, including off-label communications, medical information responses, Medical Science Liaison activities, publications, advisory boards, and pre-approval and payor communications, including PIE/HCEI under FDORA and the 21st Century Cures Act.
  • Advise on the FDCA and related FDA regulations and guidance; fraud and abuse laws, including the AKS, FCA, Civil Monetary Penalties Law, and related Office of Inspector General guidance; and federal and state transparency requirements, including the Sunshine Act/Open Payments and state marketing and price transparency laws.
  • Coordinate with Compliance to operationalize compliance in commercial activities, including policies, standard operating procedures, training, healthcare professional interactions, speaker programs, and fair market value processes.
  • Provide strategic legal advice on patient support programs, hub services, copay and patient assistance programs, independent charitable foundations, and market access and payor materials.
  • Develop and deliver training to brand, commercial, and medical teams on advertising and promotion and healthcare compliance topics, and contribute to process improvements for review committees.
  • Participate with other members of the Healthcare Law Team in monitoring and assessing emerging healthcare, drug pricing, supply chain, state law, and FDA enforcement developments, including Office of Prescription Drug Promotion untitled and warning letters, and communicate their potential impact to the company.
  • Manage outside counsel on select healthcare law and commercialization matters.
  • Support additional Legal team priorities as business needs evolve.

Desired Qualifications

  • Experience supporting product launches, including indication expansions.
  • In-house experience supporting commercial-stage marketed products.
  • Oncology or specialty/rare disease experience.
  • Experience with patient support, hub, copay/patient assistance, and market access programs.
  • Experience with digital and social media promotion.

About the Company

Revolution Medicines

Clinical-stage oncology company developing RAS inhibitors

Revolution Medicines develops precision oncology drugs focused on cancers driven by RAS mutations. Its RAS(ON) inhibitors are small molecules that bind the active form of RAS to block cancer signaling, with candidates like Daraxonrasib (RMC-6236), Elironrasib (RMC-6291), and Zoldonrasib (RMC-9805) advancing in global Phase 3 trials. The company funds its research through collaborations, royalties, and upfront funding, and has not yet marketed a product. Its goal is to bring effective RAS-targeted therapies to patients and advance multiple candidates through late-stage trials toward approval, supported by strong cash reserves.

Company size
1,001-5,000
Company stage
IPO
Headquarters
Redwood City, CA
Founded
2014

Recently Posted Jobs

Explore more opportunities at Revolution Medicines

See more jobs